首页> 中文期刊> 《中国中医基础医学杂志》 >强骨胶囊上市后临床应用文献分析

强骨胶囊上市后临床应用文献分析

         

摘要

原发性骨质疏松症是临床常见病与多发病,严重影响患者的生活质量,是目前国内外研究的热点和难点.中医学认为骨质疏松症属“骨瘘”范畴,中药二类新药强骨胶囊具有补肾、强骨、止痛的功效,临床应用广泛,适用于原发性骨质疏松症、骨量减少的肾阳虚患者,在临床实际应用中还可显著降低骨折发生率,明显改善骨代谢和骨转换指标,疗效确切,不良反应少.强骨胶囊还应用于其他骨伤科疾病的治疗,属于超说明书使用范畴.%Primary Osteoporosis is a common and frequently-occurring disease,seriously affecting the patient' s quality of life, which has been the focus and difficulty of the current domestic and international research. Traditional Chinese medicine considers primary osteoporosis as the category of "guwei". As the first traditional Second Category Novel Chinese medicine, Qianggu capsule can nourish kidney, improve bone quality, and alleviate bone pain, which has been used widespread. Qianggu capsule can reduce bone fracture happens, improving bone metabolism and turnover index, used to primary osteoporosis and bone mineral density decreasing patients with Shen-yang deficiency syndrome. Qianggu capsule also can be used to cure others disease of orthopedics and traumatology, which is beyond drug specification use.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号